EMN vs ALB
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
EMN · Eastman Chemical$64.41 ▼ 1.98%
ALB · Albemarle$99.25 ▲ 0.89%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- EMN +9.9%
- ALB -3.1%
Head to head
| Metric | EMN | ALB |
|---|---|---|
| Price | $64.41 | $99.25 |
| Change today | ▼ 1.98% | ▲ 0.89% |
| Market cap | $7.36B | $11.71B |
| Return, 3 months | -11.2% | -24.1% |
| Return, year to date | +4.6% | -29.2% |
| Return, 1 year | +10.4% | +3.3% |
| P/E (TTM) | 11.9 | 23.9 |
| P/B | 1.2 | 1.4 |
| P/E percentile vs own 5y | 32nd | 70th |
| Dividend yield | 5.22% | 1.64% |
| Revenue growth (YoY, latest qtr) | +8.3% | +31.1% |
| Net profit growth (YoY) | +438.3% | +1,318.5% |
| Gross margin | 20.6% | 23.8% |
| Operating margin | 11.0% | 13.7% |
| Net margin | 7.2% | 1.0% |
| Return on equity | – | 0.7% |
| Analyst target vs. price | +16.4% | +57.0% |
| Analyst buy share | 46% | 79% |
| RSI (14) | 46 | 51 |
| 30-day volatility | 25.5% | 35.7% |
| Max drawdown, 1 year | -20.9% | -57.9% |
| Trend read | Strong downtrend | Leaning bullish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- ALB is the largest of the group by market value.
- EMN has returned the most over the past year.
- EMN carries the lowest trailing P/E.
- EMN pays the highest dividend yield.
- ALB is growing revenue fastest.
- EMN keeps the most profit per dollar of sales.
- EMN has been the calmest stock over the last 30 days.